MDM2 and breast cancer: The PD0332991-induced downregulation of MDM2 and entry into senescence is observed in a number of different types of cancer cell lines, including those derived from well-differentiated and dedifferentiated liposarcoma (WD/DDLS), breast cancer, non-small cell lung cancer, and glioma [18].